About the Company
We do not have any company description for Arcutis Biotherapeutics, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ARQT News
Industry Analysts Just Made A Captivating Upgrade To Their Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Revenue Forecasts
Arcutis Biotherapeutics, Inc. ( NASDAQ:ARQT ) shareholders will have a reason to smile today, with the analysts ...
Evaluating Arcutis Biotherapeutics: Insights From 5 Financial Analysts
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...
Arcutis Appoints David Topper as Chief Financial Officer
We could not be more pleased to welcome David as chief financial officer at this transformational time,” said Frank Watanabe, ...
Innovative Seborrhea Treatments on the Horizon as Pipeline Report Reveals Promising Drug Candidates for 2024
Among these promising candidates, Arcutis Biotherapeutics Inc. leads with ARQ154, a topical roflumilast foam currently in phase II of clinical development. The aim is to improve the quality of life ...
The Business Case For Buying Arcutis Biotherapeutics Inc (NASDAQ: ARQT) Stock Now
A look at the daily price movement shows that the last close reads $10.20. The company’s 5Y monthly beta was ticking 1.14.
Is AdaptHealth (AHCO) Stock Outpacing Its Medical Peers This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has AdaptHealth Corp. (AHCO) been one of those stocks this year? By taking a look at ...
Analysts Advise You To Maintain Your Position In Arcutis Biotherapeutics Inc (NASDAQ: ARQT)
Arcutis Biotherapeutics Inc (NASDAQ:ARQT) traded at $11.34 at close of the session on Friday, April 05, made an upward move of 5.49% on its previous day’s price.
Are Medical Stocks Lagging AdaptHealth (AHCO) This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. AdaptHealth Corp. (AHCO) is a stock that can certainly grab the attention of many ...
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WESTLAKE VILLAGE, Calif., April 05, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in ...
Excision BioTherapeutics Announces Presentations at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
Excision to give three oral presentations and outline new data in three posters from preclinical programs for herpes keratitis (HSV-1 Keratitis) and hepatitis B virus (HBV) as well as a ...
Loading the latest forecasts...